淋巴细胞浓度作为冠状动脉疾病预后标志物的效用。
Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease.
作者信息
Ommen S R, Gibbons R J, Hodge D O, Thomson S P
机构信息
Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
出版信息
Am J Cardiol. 1997 Mar 15;79(6):812-4. doi: 10.1016/s0002-9149(96)00878-8.
PMID:9070569
Abstract
The prognostic utility of the relative lymphocyte concentration was tested in a population-based study of chronic coronary artery disease. This inexpensive, readily available test was found to be significantly related to survival (p = 0.03) in 211 patients followed for a mean of 45 months.
摘要
在一项基于人群的慢性冠状动脉疾病研究中，对相对淋巴细胞浓度的预后效用进行了测试。在平均随访45个月的211名患者中，发现这项成本低廉、易于获得的检测与生存率显著相关（p = 0.03）。
Zotero 插件